Form 8-K - Current report:
SEC Accession No. 0001558370-24-008869
Filing Date
2024-06-03
Accepted
2024-06-03 17:15:10
Documents
14
Period of Report
2024-05-28
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20240528x8k.htm   iXBRL 8-K 35366
  Complete submission text file 0001558370-24-008869.txt   164972

Data Files

Seq Description Document Type Size
2 EX-101.SCH cydy-20240528.xsd EX-101.SCH 3403
3 EX-101.LAB cydy-20240528_lab.xml EX-101.LAB 16917
4 EX-101.PRE cydy-20240528_pre.xml EX-101.PRE 11936
17 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20240528x8k_htm.xml XML 4303
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 241014895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)